| CONTENTS |
| An Enabling Technology for Parenteral Reconstitution Devices Tom Bailey, Managing Director Dave Seaward, Projects Director 3P Innovation |
| A Differentiated, Customisable Portfolio to Lead a New Era of Industry Growth Alan Shortall, CEO Unilife Corporation |
| High Volume Production: Injectable Devices on Their Path to Success Reiner Zeidler, Sales Manager Medical Systems teamtechnik Group |
| Company Profile Haselmeier |
| Tungsten Release Quantification: A Predictive Tool to Improve Compatibility with Biomolecules Daniele Zuccato, Andrea Sardella Alberto Chillon, Emanuel Guadagnino Nuova Ompi – Stevanato Group |
| A New Electronic Multiuse Auto-Injector: The Flexi-Q eMU Dr Menachem Zucker, VP, Head of Injectable Drug Delivery Devices (I3D) Elcam Medical |
| New Applications and Market Trends for Prefillable Cartridge Components Tibor Hlobik, Global Director, Marketing, PFS Technologies West Pharmaceutical Services |
| Understanding Which Types of Design Should Be Driving Innovation at Drug Delivery Device Suppliers Steven R Kaufman, Global Marketing Director SHL Group |
| Meeting The Gap in Parenteral Packaging Ralf Künzi, Medical Business Development Hoffmann Neopac |
| Part I of II: Improved Parenteral Containers Through Plasma Deposition of High-Purity Glass Dr Shawn Kinney, Consultant to SiO2 Kevin Turney, Senior Applications Development Scientist Peter Sagona, VP & Secretary SiO2 Medical Products |
| Company Profile Specialty Coating Systems |
| Patient Centric Design of a Novel Anti-Needlestick Safety Device Sarah Baer, Marketing Product Manager BD Medical – Pharmaceutical Systems, Safety |